Vutrisiran CAS#: 1867157-35-4; 凯望编码 (ChemWhat Code): 1417434
Identification
| 英文名 | Vutrisiran |
| IUPAC Name | |
| CAS编号 | 1867157-35-4 |
| 分子式 | |
| 分子量 | |
| InChI | |
| InChI Key | |
| Canonical SMILES |
Physical Data
No data available
Spectra
No data available
Route of Synthesis (ROS)
No data available
Safety and Hazards
No data available
Other Data
No data available
| Use Pattern |
| Vutrisiran CAS#: 1867157-35-4 is an investigational subcutaneously administered RNAi therapeutic indicated for the treatment of transthyretin-mediated (ATTR) amyloidosis, including hATTR and wild-type ATTR (wtATTR) amyloidosis. It blocks the production of wild-type and variant transthyretin (TTR) by targeting and silencing specific mRNAs. |
试剂采购 | |
| 没有试剂厂商? | 向凯望发送快速询价 |
| 想要被列为试剂厂商? (付费服务) | 点击这里联系凯望 |
认证生产商 | |
| Watson Bio Ltd | https://www.watson-bio.com/ |
| 想要被列为认证生产商 (需要通过认证)? | 请下载并填写 这份表格并发邮件到approved-manufacturers@chemwhat.com |
其他供应商 | |
| Watson International Limited | 访问Watson官网 |
如需其他帮助，请联系我们 | |
| 联系我们获取其它信息或服务 | 点击这里联系凯望 |